Medication info

Samchundang Ranitidine Injection (Ranitidine Hydrochloride)

Prescription medicationOral · Intramuscular injection · Intravenous injectionExpired
Ingredient · strength
Ranitidine Hydrochloride›28mg / 1mL
Manufacturer / importer
Samchundang Pharmaceutical Co., Ltd.
Appearance
Brown ampoule filled with a colorless to pale yellow transparent liquid
Packaging
2mL×1 ampoule, 50 ampoules
Approval status
Expired

MFDS item code 199100973 · Notified 1991.11.14

This product's status changed to Expired on 2025.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of gastric acid-related disorders (e.g., ulcers), suppression of upper gastrointestinal bleeding, and prevention of Mendelson's syndrome
Who uses it
Adults · Children
Adult dosage
Inject 50mg of ranitidine per dose 3-4 times daily by intravenous or intramuscular injection. For intravenous injection, dilute 50mg of this medicine in 20ml of saline or glucose injection and inject slowly over at least 2 minutes, or mix it with an infusion solution and administer by intravenous drip over 2 hours at a rate of 25mg/hr. In cases of upper gastrointestinal bleeding, the effect generally appears within 1 week. Once oral administration is possible, switch to oral administration. For preanesthetic medication (prevention of Mendelson's syndrome), inject 50mg intramuscularly or slowly intravenously over 1 minute, 45-60 minutes before induction of anesthesia. For patients with severe renal impairment and a creatinine clearance of 50ml/min or less, reduce the dose to 25mg per dose, or extend the dosing interval and administer 50mg per dose every 18-24 hours. Depending on the patient's condition, 50mg may be administered at 12-hour intervals. Hemodialysis reduces the blood concentration of the drug, so readjust the dosing schedule immediately after hemodialysis. The dose may be adjusted appropriately according to age and symptoms.
Children's dosage
Clinical studies for pediatric use have not been established.

Ingredients

Manufacturer
Samchundang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastric acid-related disorders (e.g., ulcers), suppression of upper gastrointestinal bleeding, and prevention of Mendelson's syndrome

  • Stomach ulcer
  • duodenal ulcer
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcer
  • upper gastrointestinal bleeding
  • peptic ulcer
  • acute stress ulcer
  • acute gastric mucosal lesion
View approved original text

This medication is used to treat ulcers in the stomach and duodenum, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It also helps prevent Mendelson's syndrome during preoperative anesthesia and prevents postoperative ulcers. It is effective in treating upper gastrointestinal bleeding caused by acute stress ulcers or acute gastric mucosal lesions. It is used to improve various symptoms related to gastrointestinal diseases.

Dosage and Administration

Adult dosage

Inject 50mg of ranitidine per dose 3-4 times daily by intravenous or intramuscular injection. For intravenous injection, dilute 50mg of this medicine in 20ml of saline or glucose injection and inject slowly over at least 2 minutes, or mix it with an infusion solution and administer by intravenous drip over 2 hours at a rate of 25mg/hr. In cases of upper gastrointestinal bleeding, the effect generally appears within 1 week. Once oral administration is possible, switch to oral administration. For preanesthetic medication (prevention of Mendelson's syndrome), inject 50mg intramuscularly or slowly intravenously over 1 minute, 45-60 minutes before induction of anesthesia. For patients with severe renal impairment and a creatinine clearance of 50ml/min or less, reduce the dose to 25mg per dose, or extend the dosing interval and administer 50mg per dose every 18-24 hours. Depending on the patient's condition, 50mg may be administered at 12-hour intervals. Hemodialysis reduces the blood concentration of the drug, so readjust the dosing schedule immediately after hemodialysis. The dose may be adjusted appropriately according to age and symptoms.

Children's dosage

Clinical studies for pediatric use have not been established.

Precautions

This medication should be cut carefully when using glass ampoules to avoid glass fragments. Extra caution is needed when used in children or the elderly. This medication should not be administered to patients who have had an allergic reaction to this drug or its components. Patients with impaired kidney function may require dose adjustment as this drug is excreted through the kidneys, which can lead to elevated plasma concentrations. Caution should be exercised when administering to patients with liver dysfunction, a history of hypersensitivity, elderly patients, and those with a history of acute porphyria. This medication may rarely cause serious allergic reactions or anaphylactic shock; thus, if any unusual symptoms occur during administration, it should be discontinued immediately and appropriate treatment should be received. Watch for hypersensitivity reactions such as hives, rash, and bronchospasms. Blood abnormalities may include leukopenia, thrombocytopenia, aplastic anemia, and so it is essential to get tested immediately if symptoms such as systemic fatigue, bleeding, or fever occur. Liver dysfunction may occur; if elevated liver enzymes or jaundice symptoms arise, treatment should be discontinued. Rare cardiovascular issues may include arrhythmia, bradycardia, and heart block, so caution is advised for patients with heart disease. Gastrointestinal side effects may include constipation, nausea, vomiting, and abdominal pain. There may be neurologic symptoms such as dizziness, drowsiness, seizures, and mental confusion; consult with healthcare professionals if any unusual symptoms arise. Endocrine disorders such as gynecomastia and erectile dysfunction have been reported rarely. Musculoskeletal problems like myalgia or rhabdomyolysis may also occur, so be cautious. Skin rashes or hair loss symptoms may rarely occur. This medication should be administered at the minimum effective dose with close observation of therapeutic effects; if ineffective, alternative treatments should be considered. Elderly patients or those with chronic illnesses may have an increased risk of pneumonia. Routine blood tests of liver function may be advisable with long-term high-dose treatment. Use only when oral administration is not feasible or in emergency situations, and switch back to oral administration as soon as possible. This medication may interact with other drugs, so inform healthcare providers of any medications being taken. Women who are pregnant or may become pregnant should carefully weigh the risks and benefits before use, and similar caution should be exercised during breastfeeding. Safety for pediatric use has not been fully established. This medication may cause false-positive results in certain tests, so care should be taken with testing procedures. Overdose is rare, but may require treatment such as vomiting or gastric lavage, and in severe cases, dialysis may be needed. Intramuscular injection may cause pain or induration at the injection site, so caution is needed. For patients with a risk of abnormal heart rate, the infusion rate should be slow, and the recommended rate should not be exceeded. This medication may mask symptoms of gastric cancer; thus, patients over middle age with newly developed indigestion or those with gastric ulcers should ascertain malignancy before using it. Prolonged use may bind to ocular melanins, necessitating ophthalmologic examinations.

Side effects

  • Anaphylactic shock
  • urticaria
  • angioedema
  • rash
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • vascular edema
  • granulocytopenia
Show 57 more
  • elevated serum creatinine levels
  • leukopenia
  • thrombocytopenia
  • hypoplastic bone marrow syndrome
  • aplastic anemia
  • aplastic anemia
  • hypoplastic anemia
  • eosinophilia
  • systemic malaise
  • weakness
  • subcutaneous mucosal hemorrhage
  • liver dysfunction
  • jaundice
  • hepatitis
  • bradycardia
  • atrioventricular block
  • tachycardia
  • vasculitis
  • heart asystole
  • constipation
  • nausea
  • vomiting
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • diarrhea
  • acute pancreatitis
  • dizziness
  • drowsiness
  • convulsions
  • headache
  • heaviness of the head
  • insomnia
  • agitation
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • consciousness disorders
  • liver hypertrophy muscle spasms
  • gynecomastia
  • excessive milk secretion
  • erectile dysfunction
  • decreased libido
  • joint pain
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • skin itchiness
  • acute interstitial nephritis
  • injection site pain
  • injection site induration

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a container that can block light. Additionally, it is best stored at room temperature between 1°C and 30°C. This storage method helps maintain the medication's effectiveness for a prolonged period.

Appearance and packaging

Appearance

Brown ampoule filled with a colorless to pale yellow transparent liquid

Package unit

2mL×1 ampoule, 50 ampoules

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.